Niharika Samala

13PUBLICATIONS
34CO-AUTHORS
Regenerative medicine (incl. stem cells)Groundwater quality processes and contaminated land assessmentNutritional epidemiologyRespiratory diseasesMechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 15, 2026
Editorial: MASLD In Primary Care-Risk-Stratification as the First Step to Treatment.

|Aug 27, 2025
Corrected T1 (cT1) is the most appropriate diagnosis and monitoring tool for widespread adoption of resmetirom treatment in the United States.

Marika Hancock, Cayden Beyer, Michael Fuchs

|Apr 03, 2025
Early experience with resmetirom to treat metabolic dysfunction-associated steatohepatitis with fibrosis in a real-world setting.

Neel Ravela, Phoebe Shackelford, Nadia Blessing

|Aug 16, 2024
Associations between per- and polyfluoroalkyl substance exposures and metabolic dysfunction associated steatotic liver disease (MASLD) in adult National Health and Nutrition Examination Survey 2017 to 2018.

Niharika Samala, Manjiri Kulkarni, Rachana S Lele

|Mar 14, 2024
Non-Hispanic Black Persons With Nonalcoholic Fatty Liver Disease Have Lower Rates of Advanced Fibrosis, Cirrhosis, and Liver-Related Events Even After Controlling for Clinical Risk Factors and PNPLA3 Genotype.

Niharika Samala, Yuchen Xin, Laura A Wilson

|Aug 06, 2023
Thirty-Day Readmissions Are Largely Not Preventable in Patients With Cirrhosis.

Eric S Orman, Archita P Desai, Marwan S Ghabril

Pageof 3

Frequent Collaborators

3 joint publications

Raj Vuppalanchi

2 joint publications

Marwan S Ghabril

2 joint publications

Lauren Nephew

2 joint publications

Samer Gawrieh